186 related articles for article (PubMed ID: 19372563)
1. Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.
Wei J; Kitada S; Rega MF; Emdadi A; Yuan H; Cellitti J; Stebbins JL; Zhai D; Sun J; Yang L; Dahl R; Zhang Z; Wu B; Wang S; Reed TA; Wang HG; Lawrence N; Sebti S; Reed JC; Pellecchia M
Mol Cancer Ther; 2009 Apr; 8(4):904-13. PubMed ID: 19372563
[TBL] [Abstract][Full Text] [Related]
2. Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Kitada S; Rega MF; Stebbins JL; Zhai D; Cellitti J; Yuan H; Emdadi A; Dahl R; Zhang Z; Yang L; Reed JC; Pellecchia M
J Med Chem; 2009 Jul; 52(14):4511-23. PubMed ID: 19555126
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Kitada S; Stebbins JL; Placzek W; Zhai D; Wu B; Rega MF; Zhang Z; Cellitti J; Yang L; Dahl R; Reed JC; Pellecchia M
J Med Chem; 2010 Nov; 53(22):8000-11. PubMed ID: 21033669
[TBL] [Abstract][Full Text] [Related]
4. BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Stebbins JL; Kitada S; Dash R; Placzek W; Rega MF; Wu B; Cellitti J; Zhai D; Yang L; Dahl R; Fisher PB; Reed JC; Pellecchia M
J Med Chem; 2010 May; 53(10):4166-76. PubMed ID: 20443627
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
Kitada S; Kress CL; Krajewska M; Jia L; Pellecchia M; Reed JC
Blood; 2008 Mar; 111(6):3211-9. PubMed ID: 18202226
[TBL] [Abstract][Full Text] [Related]
6. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
[TBL] [Abstract][Full Text] [Related]
7. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
[TBL] [Abstract][Full Text] [Related]
8. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
Wei J; Rega MF; Kitada S; Yuan H; Zhai D; Risbood P; Seltzman HH; Twine CE; Reed JC; Pellecchia M
Cancer Lett; 2009 Jan; 273(1):107-13. PubMed ID: 18782651
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Lin J; Wu Y; Yang D; Zhao Y
Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
[TBL] [Abstract][Full Text] [Related]
11. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.
Cao X; Yap JL; Newell-Rogers MK; Peddaboina C; Jiang W; Papaconstantinou HT; Jupitor D; Rai A; Jung KY; Tubin RP; Yu W; Vanommeslaeghe K; Wilder PT; MacKerell AD; Fletcher S; Smythe RW
Mol Cancer; 2013 May; 12(1):42. PubMed ID: 23680104
[TBL] [Abstract][Full Text] [Related]
12. Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim.
Nguyen M; Cencic R; Ertel F; Bernier C; Pelletier J; Roulston A; Silvius JR; Shore GC
BMC Cancer; 2015 Aug; 15():568. PubMed ID: 26231047
[TBL] [Abstract][Full Text] [Related]
13. Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.
Chen S; Dai Y; Pei XY; Grant S
Mol Cell Biol; 2009 Dec; 29(23):6149-69. PubMed ID: 19805519
[TBL] [Abstract][Full Text] [Related]
14. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
15. Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis.
Dai H; Meng XW; Lee SH; Schneider PA; Kaufmann SH
J Biol Chem; 2009 Jul; 284(27):18311-22. PubMed ID: 19351886
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.
Meng XW; Lee SH; Dai H; Loegering D; Yu C; Flatten K; Schneider P; Dai NT; Kumar SK; Smith BD; Karp JE; Adjei AA; Kaufmann SH
J Biol Chem; 2007 Oct; 282(41):29831-46. PubMed ID: 17698840
[TBL] [Abstract][Full Text] [Related]
17. Vesicular stomatitis virus induces apoptosis primarily through Bak rather than Bax by inactivating Mcl-1 and Bcl-XL.
Pearce AF; Lyles DS
J Virol; 2009 Sep; 83(18):9102-12. PubMed ID: 19587033
[TBL] [Abstract][Full Text] [Related]
18. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
Sun J; Li ZM; Hu ZY; Lin XB; Zhou NN; Xian LJ; Yang DJ; Jiang WQ
Anticancer Drugs; 2008 Nov; 19(10):967-74. PubMed ID: 18827561
[TBL] [Abstract][Full Text] [Related]
19. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
